VLKIM
Van Lanschot Kempen Investment Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Sell |
129,347
-93,227
| -42% | -$7.29M | 0.1% | 151 |
|
|
2025
Q1 | $16.1M | Sell |
222,574
-1,990
| -0.9% | -$144K | 0.17% | 115 |
|
|
2024
Q4 | $16.6M | Sell |
224,564
-73,191
| -25% | -$5.42M | 0.17% | 117 |
|
|
2024
Q3 | $19.6M | Buy |
297,755
+36,745
| +14% | +$2.42M | 0.2% | 113 |
|
|
2024
Q2 | $24.1M | Buy |
261,010
+36,901
| +16% | +$3.41M | 0.27% | 90 |
|
|
2024
Q1 | $21.4M | Buy |
+224,109
| New | +$21.4M | 0.27% | 94 |
|
|
2023
Q1 | – | Sell |
-13,132
| Closed | -$980K | – | 216 |
|
|
2022
Q4 | $980K | Buy |
13,132
+1,195
| +10% | +$89.2K | 0.03% | 171 |
|
|
2022
Q3 | $986K | Sell |
11,937
-3,802
| -24% | -$314K | 0.04% | 158 |
|
|
2022
Q2 | $1.5M | Sell |
15,739
-1,465
| -9% | -$139K | 0.05% | 152 |
|
|
2022
Q1 | $2.03M | Buy |
17,204
+2,493
| +17% | +$293K | 0.06% | 149 |
|
|
2021
Q4 | $1.91M | Buy |
+14,711
| New | +$1.91M | 0.06% | 141 |
|